Revelol-CH 50mg/12.5mg Tablet ER
Marketer
Ipca Laboratories Ltd
Salt Composition
Metoprolol Succinate (50mg) + Chlorthalidone (12.5mg)
Overview Revelol-CH 50mg/12.5mg Tablet ER
Cardio-CH 50mg/12.5mg Extended-Release tablets manage hypertension (high blood pressure) when other treatments prove insufficient. This medication helps regulate blood pressure, lessening the risk of future strokes and heart attacks. Prompt treatment significantly improves survival rates following a heart attack. Cardio-CH 50mg/12.5mg ER tablets are taken once daily, preferably in the morning, with or without food, to minimize nighttime urination. Continue taking this medication as directed; discontinuation, even with symptom improvement, can worsen your condition as high blood pressure often presents asymptomatically. Maintaining a healthy lifestyle, including regular exercise, weight management, and a balanced diet, complements this treatment. Always follow your physician's instructions. Common side effects include nausea, constipation, diarrhea, and fatigue. Report any persistent, worsening, or bothersome side effects to your doctor. Increased fluid intake can alleviate muscle weakness, dry mouth, and thirst. Initial dizziness or headaches, potentially due to lowered blood pressure, usually subside. Inform your doctor about any pre-existing liver or kidney conditions, and pregnant or breastfeeding individuals should seek medical advice before use. Disclose all other medications, particularly those for heart conditions or hypertension. Regular monitoring of blood pressure, kidney function, blood sugar, and electrolyte levels (potassium and magnesium) is crucial to assess treatment effectiveness.
Uses of Revelol-CH 50mg/12.5mg Tablet ER
Elevated blood pressure
Major Benefits of Revelol-CH 50mg/12.5mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Revelol-CH 50mg/12.5mg Extended-Release tablet whole; do not crush, chew, or divide it. While you can consume it with or without food, consistency is key – take it at the same time each day.
Common Side effects of Revelol-CH 50mg/12.5mg Tablet ER:
- Nausea
- Constipation
- Diarrhea
- Fatigue
- Headache
- Dizziness
- Slow heart rate
- Increased blood uric acid
- Decreased potassium level in blood
- Glucose intolerance
- Altered blood lipid level
- Cold extremities
- Decreased magnesium level in blood
- Increased calcium level in blood
How to use Revelol-CH 50mg/12.5mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Revelol-CH 50mg/12.5mg Extended-Release Tablets can be consumed with or without food, although consistent daily timing is recommended.
How Revelol-CH 50mg/12.5mg Tablet ER works:
Each Revelol-CH 50mg/12.5mg extended-release tablet combines metoprolol succinate, a beta-blocker, with chlorthalidone, a diuretic, to effectively manage hypertension. Metoprolol succinate acts on the heart, decreasing heart rate and improving its pumping efficiency. Chlorthalidone reduces blood pressure by promoting fluid and electrolyte excretion, and also contributes to vasodilation and improved circulation over time.
SAFETY ADVICE
AlcoholUNSAFE
Combining Revelol-CH 50mg/12.5mg extended-release tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Revelol-CH 50mg/12.5mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. Prescribing will depend on your physician's assessment of the risks versus benefits. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Revelol-CH 50mg/12.5mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Revelol-CH 50mg/12.5mg tablets can cause drowsiness, blurred vision, and dizziness. Driving is discouraged if these effects are experienced.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Revelol-CH 50mg/12.5mg Extended-Release tablets, as dosage modification may be necessary. Consult a physician before use; administration is generally inadvisable in such cases.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Revelol-CH 50mg/12.5mg extended-release tablets. Dosage modification may be necessary. Physician consultation is advised. Revelol-CH 50mg/12.5mg extended-release tablets are contraindicated in patients with severe liver disease.
What if you forget to take Revelol-CH 50mg/12.5mg Tablet ER :
Should you forget a dose of Revelol-CH 50mg/12.5mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Revelol-CH 50mg/12.5mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |



